Discovery of isoxazolyl-based inhibitors of Plasmodium falciparum cGMP-dependent protein kinase.
RSC Med Chem
; 11(1): 98-101, 2020 Jan 01.
Article
em En
| MEDLINE
| ID: mdl-33479608
The cGMP-dependent protein kinase in Plasmodium falciparum (PfPKG) plays multiple roles in the life cycle of the parasite. As a result, this enzyme is a potential target for new antimalarial agents. Existing inhbitors, while potent and active in malaria models are not optimal. This communication describes initial optimization of a structurally distinct class of PfPKG inhibitors.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article